Regis Technologies Inc.

Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite their drug candidates to market. Regis has the technical and operational capabilities to fully support our clients` preclinical and clinical API needs. We offer a full range of services to support the development of our clients` lead molecules through commercialization, including process research and development, analytical and stability services, GMP and API manufacturing. With extensive organic chemistry expertise and collegiate collaborations, we also offer an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.